Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

September 30, 2017

Conditions
Hepatocellular Carcinoma
Interventions
RADIATION

Stereotactic body radiotherapy

"Total stereotactic Body radiotherapy (SBRT) doses will be 60 Gy in 3 fractionations. Patients receive 3 fractionations separated by \>48 hours.~At least 700 ml of normal liver (entire liver minus cumulative GTV) should not receive a total dose of \> 17 Gy in three fractions. If volume of normal liver does not exceed 700 ml, at least 70% of normal liver should not receive a total dose of \> 17 Gy. In patients without gastroduodenal ulcer on Esophagogastroduodenoscopy (EGD) before SBRT, D2ml of gastrointestinal tract should not exceed 35 Gy. In patients with gastroduodenal ulcer on EGD before SBRT, D2ml of gastrointestinal tract should exceed 28 Gy. (D2ml: minimum dose to 2 ml of gastrointestinal tract)"

Trial Locations (7)

612-896

Inje University Haeundae Paik Hospital, Busan

Unknown

Dongnam Institute of Radiological & Medical Sciences, Busan

Soon Chun Hyang University Hospital Cheonan, Cheonan

Catholic University Incheon St. Mary's Hospital, Incheon

Inha University Hospital, Incheon

Soon Chun Hyang University Hospital Seoul, Seoul

139-706

Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul

All Listed Sponsors
collaborator

Dongnam Institute of Radiological & Medical Sciences

OTHER

collaborator

Soonchunhyang University Hospital

OTHER

collaborator

Inje University

OTHER

collaborator

Inha University Hospital

OTHER

collaborator

Incheon St.Mary's Hospital

OTHER

lead

Korea Cancer Center Hospital

OTHER

NCT01850667 - Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter